Joo K-I, Wang P
Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA.
Gene Ther. 2008 Oct;15(20):1384-96. doi: 10.1038/gt.2008.87. Epub 2008 May 15.
We have reported a method to target lentiviral vectors to specific cell types. This method requires the incorporation of two distinct molecules on the viral vector surface: one is an antibody that renders the targeting specificity for the engineered vector, and the other is a fusogenic protein that allows the engineered vector to enter the target cell. However, the molecular mechanism that controls the targeted infection needs to be defined. In this report, we tracked the individual lentiviral particles by labeling the virus with the GFP-Vpr fusion protein. We were able to visualize the surface-displayed proteins on a single virion as well as antibody-directed targeting to a desired cell type. We also demonstrated the dynamics of virus fusion with endosomes and monitored endosome-associated transport of viruses in target cells. Our results suggest that the fusion between the engineered lentivirus and endosomes takes place at the early endosome level, and that the release of the viral core into the cytosol at the completion of the virus-endosome fusion is correlated with the endosome maturation process. This imaging study sheds some light on the infection mechanism of the engineered lentivirus and can be beneficial to the design of more efficient gene delivery vectors.
我们已经报道了一种将慢病毒载体靶向特定细胞类型的方法。该方法需要在病毒载体表面掺入两种不同的分子:一种是赋予工程化载体靶向特异性的抗体,另一种是使工程化载体能够进入靶细胞的融合蛋白。然而,控制靶向感染的分子机制仍有待确定。在本报告中,我们通过用绿色荧光蛋白-Vpr融合蛋白标记病毒来追踪单个慢病毒颗粒。我们能够可视化单个病毒粒子表面展示的蛋白质以及抗体介导的对所需细胞类型的靶向作用。我们还展示了病毒与内体融合的动力学,并监测了靶细胞中与内体相关的病毒转运。我们的结果表明,工程化慢病毒与内体之间的融合发生在早期内体水平,并且在病毒-内体融合完成时病毒核心释放到细胞质中与内体成熟过程相关。这项成像研究为工程化慢病毒的感染机制提供了一些线索,并且可能有助于设计更高效的基因递送载体。